Overview

Collection of Breath and Sweat to Identify Indicators of Hypoglycemia

Status:
Unknown status
Trial end date:
2020-01-01
Target enrollment:
Participant gender:
Summary
Breath and sweat samples will be collected at intervals throughout the visit, with increased frequency during hypoglycemia. Collaborators with the MITRE Corporation will perform analyses on these samples to identify any relationships between volatile organic compounds in breath and sweat and hypoglycemia.
Phase:
Phase 2
Details
Lead Sponsor:
Massachusetts General Hospital
Collaborator:
Mitre Medical Corp.
Treatments:
Insulin
Insulin Lispro
Insulin, Globin Zinc